title: Is light transmittance aggregometry still a useful tool to assess pharmacodynamic effects of antiplatelet therapy?
authors.affiliation: Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore , Baltimore, MD , USA.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Gurbel
authors.forename: Martin G
authors.initials: MG
authors.lastname: Gesheff
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Franzese
authors.forename: Kevin P
authors.initials: KP
authors.lastname: Bliden
authors.forename: Udaya S
authors.initials: US
authors.lastname: Tantry
mesh_terms: D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000493:pharmacokinetics* / Q000627:therapeutic use; D010979:Platelet Function Tests / Q000379:methods*; D015203:Reproducibility of Results
chemical_list: D010975:Platelet Aggregation Inhibitors
keywords: Antiplatelet therapy; light transmittance aggregometry; platelet function testing